Evidence map›Paper›PMID 42651368›Full record

ReviewHealthcare (Basel, Switzerland)2026

From Product-Quality Complaints to Patient-Safety Triage: A Structured Narrative Review and Proposed PRCS-TRACE Framework.

Sabihe Cenaj, Erand Llanaj

Abstract readReview
In one paragraph

Review in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sabihe CenajFaculty of Medicine, University of Medicine, 1005 Tirana, Albania.ORCID 0009-0002-1852-8578
Erand LlanajWorking Group Translational Research and Health Services Research in General Practice, Medical Faculty OWL, Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0003-4300-0433

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Product-quality complaints are usually handled as pharmaceutical quality-system events, yet defects in sterility, potency, identity, packaging, labelling, storage, distribution or delivery-device function may affect medication use, treatment continuity and patient outcomes. This structured narrative review examines product-quality complaints (PQCs) as a patient-safety interface linking pharmaceutical quality systems, pharmacovigilance, medication-error prevention, recall action and pharmacoepidemiology. Existing pharmacovigilance, quality-management and recall systems address different components of this pathway, but no integrated framework was identified in the sources reviewed that specifies how product-quality complaints should be linked to exposure evidence and patient outcomes. Sources were identified through targeted PubMed searches and purposive retrieval of official regulatory, pharmacovigilance and public-health documents up to 5 June 2026; the review was not registered and included no quantitative synthesis. The sources identified concentrate on regulatory architecture, sentinel contamination events and shortage-associated harms; routine complaints are studied comparatively little, and no source identified reported the complaint-to-defect-to-exposure-to-outcome cascade with a complaint-level denominator. We propose the term patient-relevant complaint status (PRCS) for a complaint warranting patient-safety triage because the reported defect could plausibly affect exposure, sterility, potency, identity, delivery, medication use or treatment continuity, together with a TRACE workflow, a six-level clinical-consequence classification and separately graded certainty for defect confirmation, patient exposure and outcome attribution. These tools are proposed, unvalidated and hypothesis-generating; they do not convert complaints into adverse reactions, recalls into causality or spontaneous reports into incidence. Their intended role is to structure patient-safety triage, batch-aware linkage, exposure reconstruction, clinical follow-up and proportionate mitigation while causal attribution remains incomplete; this role requires prospective validation before routine implementation.

Indexed as

drug recallshealthcare deliverymedication errorsmedication managementpatient safetypharmacoepidemiologypharmacovigilanceproduct-quality complaintssignal detectionsubstandard and falsified medicines

Identifiers

PMID42651368
PMCPMC13512497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.